Imax (IMAX) EBITDA (2010 - 2026)

Imax (IMAX) has reported EBITDA for 17 consecutive years, with $20.8 million the latest figure, recorded in Q2 2026.

• Quarterly EBITDA rose 44.81% year-over-year to $20.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $83.9 million (up 39.78% YoY) and the FY2025 annual result came in at $84.2 million, up 92.03% from the prior year.
• EBITDA climbed to $20.8 million in Q2 2026 per IMAX's latest filing, from $10.0 million in the prior quarter.
• Over the last five years, EBITDA for IMAX reached as high as $29.0 million in Q3 2025 and fell as low as -$8.0 million in Q1 2022.
• A 5-year average of $11.4 million and a median of $11.7 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA plunged 396.83% — and 2023, when it surged 14185.15%.
• Year by year, EBITDA stood at $7.5 million in 2022, then tumbled by 63.66% to $2.7 million in 2023, then soared by 247.28% to $9.5 million in 2024, then soared by 153.41% to $24.1 million in 2025, then dropped by 13.82% to $20.8 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $20.8 million, $10.0 million, and $24.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.